证券代码：603717 证券简称：天域生物 公告编号：2025-113 天域生物科技股份有限公司 关于公司 2025 年度对外担保预计的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 公司分别于 2025 年 04 月 15 日、05 月 06 日召开公司第四届董事会第三十 八次会议和 2024 年年度股东大会，会议审议通过了《关于公司 2025 年度对外担 保预计的议案》，同意公司及控股子公司为其他下属资产负债率低于 70%的子公 司提供担保额度不超过 12.70 亿元，公司及控股子公司为其他下属资产负债率 70%以上的子公司提供担保额度不超过 35.65 亿元；公司为资产负债率低于 70% 的参股公司提供担保额度不超过 2.20 亿元。担保期限自 2024 年年度股东大会审 议通过之日起至 2025 年年度股东会召开之日止。担保业务包括：公司对控股子 公司提供的担保；控股子公司之间的担保；公司对参股子公司以持股比例为限提 供等比例担保；由第三方担保机构为下属子公司或公司的相关业务提供担保，公 司或下属子公司向第三 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：603717 证券简称：天域生物 公告编号：2025-112 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： 公司控股一级子公司天乾食品原向湖北枝江农村商业银行股份有限公司（以下简称"枝江农商行"）申请 的授信额度到期，现为满足经营发展需要，天乾食品拟继续向枝江农商行申请1,000.00万元授信额度， 授信期限三年，由公司为其提供连带责任保证担保，保证金额为1,000.00万元，保证期间自主合同项下 的借款期限届满或借款展期后届满之次日起三年。近日，公司与枝江农商行续签了《最高额保证合 同》。 （二） 内部决策程序 4、保证期间：自主合同项下的借款期限届满或借款展期后届满之次日起三年。 ● 担保对象及基本情况 ● 累计担保情况 一、 担保情况概述 （一） 担保的基本情况 二、 被担保人基本情况 （一）基本情况 三、 最高额保证合同的主要内容 四、 担保的必要性和合理性 本次担保事项主要为满足控股子公司业务发展及生产经营的需要，有利于控股子公司的持续发展 ...

重要内容提示： 担保对象及基本情况 | | 被担保人名称 | | | 天乾食品有限公司（以下简称"天乾 | | --- | --- | --- | --- | --- | | | | 食品"） | | | | | 本次担保金额 | 1,000.00 | 万元 | | | 担保对象 | 实际为其提供的担保余额 | 1,000.00 | 万元 | | | | 是否在前期预计额度内 | 是 | □否 | □不适用：_________ | | | 本次担保是否有反担保 | □是 | 否 | □不适用：_________ | 证券代码：603717 证券简称：天域生物 公告编号：2025-112 天域生物科技股份有限公司 关于公司 2025 年度对外担保预计的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 累计担保情况 | 对外担保逾期的累计金额（万元） | / | | --- | --- | | 截至本公告日上市公司及其控股子 | | | 公司对外担保总额（万元） | 107,676.13 | | （实际发生的担保余额， ...

天域生物公告称，其控股一级子公司天乾食品原向枝江农商行申请的授信额度到期，现拟继续申请1000 万元授信额度，期限三年，公司为其提供连带责任保证。近日，公司与枝江农商行续签《最高额保证合 同》，保证期间自主合同项下借款期限届满次日起三年。天域生物持股天乾食品90%，截至公告日，公 司及控股子公司实际对外担保累计金额10.77亿元，占最近一期经审计净资产比例为207.57%，无逾期担 保情况。 ...

2025年11月养殖业务主要经营数据公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 天域生物科技股份有限公司 天域生物科技股份有限公司（以下简称"公司"）现将2025年11月养殖业务主要经营数据公告如下： 一、2025年11月养殖行业主要经营数据 证券代码：603717 证券简称：天域生物 公告编号：2025-111 二、特别提示 1、上述经营数据均未经审计，与定期报告披露的数据之间可能存在差异，因此仅作为阶段性数据供投 资者参考。 2、基于生猪市场价格大幅波动以及公司投苗节奏变化等因素影响，未来公司生猪销售数量和销售收入 存在月度波动风险，敬请广大投资者注意投资风险。 特此公告。 天域生物科技股份有限公司 2025年11月，公司销售生猪1.76万头，销售收入2,432.36万元，环比变动分别为-61.57%、-55.80%，同 比变动分别为-22.00%、-45.15%。 2025年1-11月，公司累计销售生猪33.96万头，同比上升21.26%；累计销售收入47,452.09万元，同比下 降8.75%。 2025年1 ...

Group 1 - Cambridge Technology plans to invest 400 million yuan to establish a fund focused on optical devices and chips, aiming to invest in early-stage and growth-stage companies in the hard technology sector [1] - Tunnel Corporation's consortium won a bid for a highway project in Henan with a total investment of 6.49 billion yuan, using a BOT model for a 33.25-year cooperation period [2] - Hongrun Construction won a bid for a project worth 230 million yuan, which represents 3.88% of the company's projected revenue for 2024 [3] Group 2 - Tongrentang's product, Canling Baizhu Powder, received product registration approval from Health Canada, aimed at treating symptoms related to spleen and stomach weakness [4] - Hunan Baiyin announced a scheduled annual maintenance from December 9, 2025, to January 5, 2026, for equipment and facilities [5] - Changchun Gaoxin's subsidiary had two drugs included in the national medical insurance catalog for 2025 [6] Group 3 - Dongfang Securities' chairman resigned due to work relocation [7] - Xuantai Pharmaceutical's product, Sitagliptin Metformin Sustained-Release Tablets, was renewed for inclusion in the national medical insurance catalog [8] - ST Weihai was pre-selected for a smart agriculture EPC project with a bid of 652 million yuan, accounting for 26.27% of the company's projected revenue for 2024 [9] Group 4 - Guoxin Technology successfully tested an anti-quantum password financial POS chip, supporting both traditional and quantum-resistant algorithms [10] - Huaren Health's subsidiary received acceptance for a drug registration application for Lactulose Oral Solution, a common laxative [11] - Ankai Bus reported a 57.71% year-on-year increase in sales for the first 11 months of the year [12] Group 5 - Zhongyan Dadi's subsidiary won a bid for a project worth 73.86 million yuan [13] - Zhejiang Rongtai plans to invest 77 million USD in a factory in Thailand, focusing on mica paper and robot components production [14] - Optoelectronics plans to use up to 450 million yuan of idle funds for cash management [15] Group 6 - Tianyu Biological reported a 45.15% year-on-year decline in sales revenue from pig sales in November [16] - Daqin Railway's cargo transport volume increased by 1.75% year-on-year in November [17] - Yabo Co. won a bid for a heavy truck charging station project worth 3.616 million yuan [18] Group 7 - Hongri Pharmaceutical's product continues to be included in the national medical insurance catalog [19] - Jinggong Steel Structure signed a contract for steel structure installation worth approximately 470 million yuan for an overseas project [20] - Xizang Pharmaceutical's product, Xinhuasuan, continues to be included in the national medical insurance catalog [21] Group 8 - Guangdong Electric Power A announced the successful commissioning of a 1000MW unit at the Maoming Boge Power Plant [22] - Fuan Pharmaceutical's product, Palivizumab Injection, was newly included in the national medical insurance catalog [23] - Lizhu Group reported that 194 products were included in the 2025 national medical insurance catalog [24] Group 9 - Haisan Pharmaceutical's injection of Lantanol was included in the national medical insurance catalog [25] - Zhongtong Bus reported a 39.53% year-on-year increase in sales volume in November [26] - Shaanxi Coal Industry reported a 6.03% year-on-year increase in coal production in November [27] Group 10 - Haooubo's subsidiary received a medical device registration certificate for an IgG4 testing kit [28] - Yaopi Glass plans to invest 690 million yuan in new automotive glass production lines [30] - Huadian International completed the issuance of 2 billion yuan in medium-term notes [31] Group 11 - Zhongzai Zihuan's subsidiary won a bid for a green recycling project worth 205 million yuan [32] - Dabeinong reported a 25.26% year-on-year decline in sales revenue from pig sales in November [33] - Xiangjia Co. reported a 3.77% year-on-year increase in live poultry sales revenue in November [34] Group 12 - Huanxu Electronics reported a consolidated revenue of 5.198 billion yuan in November, a decrease of 3.34% year-on-year [35] - Aonong Biological reported a 72.21% year-on-year increase in pig sales volume in November [36] - Samsung Medical's subsidiary was pre-selected for a procurement project worth approximately 108 million yuan [37]

智通财经APP讯，天域生物(603717.SH)发布公告，11月，公司销售生猪1.76万头，销售收入2,432.36万 元，环比变动分别为-61.57%、-55.80%，同比变动分别为-22.00%、-45.15%。1-11月，公司累计销售生 猪33.96万头，同比上升21.26%;累计销售收入4.75亿元，同比下降8.75%。 ...

Group 1 - The company, Tianyu Biological (603717.SH), reported sales of 17,600 pigs in November, with sales revenue of 24.32 million yuan, representing a month-on-month decline of 61.57% in volume and 55.80% in revenue [1] - Year-on-year comparisons for November show a decrease of 22.00% in sales volume and 45.15% in sales revenue [1] - From January to November, the company sold a total of 339,600 pigs, which is an increase of 21.26% year-on-year, while the cumulative sales revenue reached 475 million yuan, reflecting a year-on-year decline of 8.75% [1]

格隆汇12月8日｜天域生物公告，2025年11月，公司销售生猪1.76万头，销售收入2,432.36万元，环比变 动分别为-61.57%、-55.80%，同比变动分别为-22.00%、-45.15%。2025年1-11月，公司累计销售生猪 33.96万头，同比上升21.26%；累计销售收入47,452.09万元，同比下降8.75%。2025年11月末，公司生猪 存栏18.80万头，同比上升3.45%，环比上升9.83%。 ...

格隆汇12月8日丨天域生物(603717.SH)公布，2025年11月，公司销售生猪1.76万头，销售收入2,432.36万 元，环比变动分别为-61.57%、-55.80%，同比变动分别为-22.00%、-45.15%。2025年1-11月，公司累计 销售生猪33.96万头，同比上升21.26%；累计销售收入47,452.09万元，同比下降8.75%。2025年11月末， 公司生猪存栏18.80万头，同比上升3.45%，环比上升9.83%。 ...